A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

Antibody-drug conjugates deliver chemotherapy by fusing a linker to a monoclonal antibody that attaches to a specific target expressed on cancer cells. Inside the cancer cell, a poisonous chemical ...

Monoclonal antibodies are biologic drugs (protein drugs made using living ... and various types of cancer. Interaction result: Taking Rystiggo with a monoclonal antibody can make the monoclonal ...

As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

These laboratory-made proteins are widely used in treatments for diseases such as cancer ... antibodies as a treatment." Monoclonal antibodies are the largest group of biologic drugs, which ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...